Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 41,639 | 45,641 | 57,172 | 56,888 | 41,935 |
| Operating Income | -41,639 | -45,641 | -57,172 | -56,888 | -41,935 |
| Other Income | 5,439 | -23,364 | -5,358 | 45,705 | 5,218 |
| Pre-tax Income | -36,200 | -69,005 | -62,530 | -11,183 | -36,717 |
| Net Income Continuous | -36,200 | -69,005 | -62,530 | -11,183 | -36,717 |
| Net Income | $-36,200 | $-69,005 | $-62,530 | $-11,183 | $-36,717 |
| EPS Basic Total Ops | -0.36 | -0.74 | -1.18 | -0.15 | -0.49 |
| EPS Basic Continuous Ops | -0.43 | -0.88 | -0.89 | -0.19 | -0.61 |
| EPS Diluted Total Ops | -0.36 | -0.74 | -1.18 | -0.15 | -0.49 |
| EPS Diluted Continuous Ops | -0.43 | -0.88 | -0.89 | -0.19 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.74 | -0.70 | -0.15 | -0.49 |
| EBITDA(a) | $-41,639 | $-45,641 | $-57,172 | $-56,888 | $-41,935 |